11 Best Long-Term Penny Stocks to Buy Now
The Federal Reserve’s historic battle against inflation that started in 2022 has highlighted the importance of an already-known fact: if you want to beat inflation always invest money wisely with a ...
Heron Therapeutics Inc. (HRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 11,750,000 | $13,630,000 | 0.58% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 8,131,678 | $9,432,746 | 0.05% | |
| 3. | Great Point Partners Jeffrey Jay And David Kroin | 4,737,368 | $5,495,347 | -19% | 1.07% |
| 4. | Velan Capital Adam Morgan | 4,500,000 | $5,220,000 | 4.84% | |
| 5. | Clearline Capital Marc Majzner | 2,665,984 | $3,092,542 | +28% | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.37 | 2,486,744 | Director | 6,986,744 | 2023-07-21 | Filing | |
| $17.50 | 285,714 | Director | 5,799,810 | 2019-10-04 | Filing | |
| $17.50 | 4,571 | Officer, Director | 94,652 | 2019-10-03 | Filing | |
| $17.50 | 5,143 | Officer, Director | 18,143 | 2019-10-03 | Filing | |
| $17.55 | 3,000 | Director | 13,000 | 2019-05-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.76 | 1,504 | Officer, Director | 10,872 | 2022-05-03 | Filing | |
| $9.73 | 300 | Director | 3,200 | 2021-12-21 | Filing | |
| $9.73 | 250 | Director | 2,840 | 2021-12-21 | Filing | |
| $12.31 | 300 | Director | 3,500 | 2021-09-21 | Filing | |
| $12.30 | 250 | Director | 3,090 | 2021-09-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,376,568 | $9,716,820 | 0% | |
| 2. | 8,140,722 | $9,443,237 | 0% | |
| 3. | 7,458,052 | $8,651,341 | 0% | |
| 4. | 6,855,611 | $7,952,509 | 0% | |
| 5. | 4,143,649 | $4,806,633 | 0.12% |
News See All
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q1 2023 Earnings Conference.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Heron Therapeutics Fourth Quarter 2022 Earnings Conference. As a reminder, this conference is being recorded.
15 Most Shorted Stocks Hedge Funds Are Buying
The year 2022 has been a dynamic year for financial markets worldwide.
12 Best Affordable Stocks to Buy Under $5
Third Point, a New York-based financial advisor, published its third-quarter 2022 investor letter back in October, in which the fund highlighted its market outlook.
10 Most Shorted Stocks in September
In the past two years, short squeezes have become a hot and a controversial topic on Wall Street.
5 WallStreetBets Stocks Gaining in August
Heron Therapeutics, Inc. (NASDAQ:HRTX) is a California-based biotechnology company, engaged in formulating treatments for unmet needs for cancer patients.
5 Most Shorted Stocks to Watch in July
The company is competing with JetBlue Airways Corporation (NASDAQ:JBLU) for the acquisition of Spirit Airlines, Inc. (NYSE:SAVE). Frontier Group Holdings, Inc.
5 Most Shorted Stocks to Watch
Arcimoto, Inc. (NASDAQ:FUV) is a Eugene, Oregon-based electric vehicle company that manufactures two-wheel and three-wheel fun utility vehicles (FUV).
Billionaire Hedge Funds
